Advanced in Calcinosis

Chih-kang E. Chiang

National Taiwan University Hospital BeiHu Branch, 
TPQ, TW 
Advanced in Calcinosis
National Taiwan University Hospital BeiHu Branch, 
TPQ, TW 
OverviewLocationsClinical Research

Overview

Chih-kang Chiang practices in Taiwan. Chiang is rated as an Advanced expert by MediFind in the treatment of Calcinosis. Their top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Calcinosis, and Secondary Peritonitis.

Their clinical research consists of co-authoring 132 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 9 articles in the study of Calcinosis.

Locations

National Taiwan University Hospital BeiHu Branch, TPQ, Taiwan
Other Locations
7 Chung Shan South Road, 100, TPQ, Taiwan
Renai Branch, Taipei, TNQ, Taiwan
Jinshan Branch, Jinshan, TPQ, Taiwan
NO.7, Chung Shan South Road, Zhong Zheng District, TPQ 10002, Taiwan
No. 7, Zhongshan S. Rd, TPQ 10002, Taiwan
No. 17 Xu Zhou Road, TPQ 10055, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Study of PBF-1681 Comprising a 16-week, Placebo-controlled, Double-blind Randomized Period and an 8-week, Open-label Extension Period for the Treatment of Iron Deficiency Anemia in Patients With Non-Dialysis Dependent CKD
A Phase 3 Study of PBF-1681 Comprising a 16-week, Placebo-controlled, Double-blind Randomized Period and an 8-week, Open-label Extension Period for the Treatment of Iron Deficiency Anemia in Patients With Non-Dialysis Dependent CKD
Enrollment Status: Completed
Publish Date: June 29, 2025
Intervention Type: Drug
Study Drug: Ferric Citrate
Study Phase: Phase 3
A Phase I/II Study to Evaluate the Safety and Efficacy of Allogeneic Infusion of Adipose-Derived Stem Cells in Moderate to Severe Chronic Kidney Disease
A Phase I/II Study to Evaluate the Safety and Efficacy of Allogeneic Infusion of Adipose-Derived Stem Cells in Moderate to Severe Chronic Kidney Disease
Enrollment Status: Completed
Publish Date: February 09, 2024
Intervention Type: Drug
Study Drug: ELIXCYTE
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

132 Total Publications

Predictive factors and survival associated with varying degrees of cytopenia in patients undergoing chronic Hemodialysis: A cohort study.
Predictive factors and survival associated with varying degrees of cytopenia in patients undergoing chronic Hemodialysis: A cohort study.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: August 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chiang's expertise for a condition
ConditionClose
      View All 17 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile